Literature / Brochures

Capitalizing on the Outsourcing Option

Released by DPT Laboratories 07.13.13

This document explains how and why a contract development and manufacturing organization (CDMO) can help your business thrive under changing market conditions. It also provides tips for initiating, building and maintaining a service provider relationship that benefits both parties.

THIS IS AN EBOOK!

More Literature / Brochures by DPT Laboratories

Brochures

Sterile Manufacturing of Semi-Solids and Liquids

The role of sterility is a simple one–it is to protect people against infection and contamination, which is a particular issue when sterile products are used in seriously ill people whose immune systems are already compromised. Because of…
07.13.13
Brochures

About DPT Brochure

A Contract Development and Manufacturing Organization DPT is a contract development and manufacturing organization (CDMO) providing companies the best solutions to their sterile and non-sterile pharmaceutical development and manufacturing needs thr…
04.02.12

More Content From DPT Laboratories

Drug Development | Formulation Development

Paul H. Johnson, Group President & COO

With DPT, pharmaceutical development and manufacturing piece together seamlessly.

Videos Released on 01.27.2014
Risk Management

What is Quality by Design? (QbD)

QbD is a systematic approach to pharmaceutical drug manufacturing development. QbD is built on a deeper understanding of the causes and effects of variability in the manufacturing process. This understanding is based on sound science and risk managem…

White Papers / Tech Papers Released on 01.13.2014
WHAT IS QUALITY BY DESIGN (QbD) – AND WHY SHOULD YOU CARE?

Is your development or manufacturing operation experiencing cost over-runs and unproductive delays? Do you want to optimize your development dollars and ensure a robust commercial process? You are not alone. The conventional development process uses…

White Papers / Tech Papers Released on 01.13.2014
Drug Development | Process Development

QbD BASED SCALE UP SERVICES — THE DPT LABS APPROACH

This paper describes the approach and benefits of using DPT Labs’ QbD Scale Up service and follows the third paper in our Thought Leadership Series, “QbD Based Process Development Services – The DPT Labs Approach.” In that pa…

White Papers / Tech Papers Released on 01.13.2014
Drug Development | Process Development

QbD BASED PROCESS DEVELOPMENT SERVICE — THE DPT LABS APPROACH

This paper describes the approach and benefits of using DPT Labs’ QbD Process Development service and follows the second paper in our Thought Leadership Series, “QbD Based Formulation Services – The DPT Approach.” In that pap…

White Papers / Tech Papers Released on 01.13.2014
Formulation Development

QbD BASED FORMULATION SERVICES — THE DPT LABS APPROACH

This paper describes the approach and benefits of using DPT Labs’ QbD Formulation service and follows the previous paper in our Thought Leadership Series, “What is QbD and Why Should You Care?” DPT Labs’ QbD Formulation servi…

White Papers / Tech Papers Released on 01.13.2014
APIs | Supply Chain

MANAGING THE COMPLEXITIES OF GLOBAL PHARMACEUTICAL SOURCING

With the increased globalization and complexity of the pharmaceutical supply chain, managing the sourcing of materials has become extremely challenging. Reducing time and costs are important goals of sourcing, but increased regulations and more rigor…

White Papers / Tech Papers Released on 01.13.2014
Drug Development

DPT LABORATORIES, CONFAB ANNOUNCE INTEGRATION

SAN ANTONIO, TEXAS, Oct. 16, 2013 – Pharmaceutical contract development and manufacturing organizations (CDMOs) DPT Laboratories , based in San Antonio, Texas, and Confab , based in Saint-Hubert, Quebec, today announced the integration of the o…

News Releases Released on 10.16.2013
Parenterals | Validation

Sterile and Specialty Services: from Development to Distribution with DPT Labs

In this video, Gene Ciolfi, Vice President and General Manager of DPT Lakewood, discusses the sterile and specialty development and manufacturing services that DPT Labs offers.

Videos Released on 10.03.2013
Injectables

Minimally Invasive Method for Delivery of Iron-Dextran via Transdermal Route

The objective of the research was to assess the feasibility of delivery of Iron-Dextran via transdermal route with the aid of microneedles to treat Iron Deficiency Anemia in hairless rat model. Technology used in the research has the potential to rep…

Posters Released on 07.13.2013
Using Quality by Design Approach to Correlate Patient Usage to the In Vitro Performance of a Nasal Spray Product

This study shows how high-resolution measurements of human usage (“ergonometrics”) of a commercially available nasal spray pump device vary between different age groups of people, including the effect of dominant vs. non-dominant hand, an…

Posters Released on 07.13.2013
Drug Development | Validation

Validation of a Particle Size Determination Method for Nano-particles by Dynamic Laser Light Scattering

R&D experts explain why particle size analysis is of paramount importance in pharmaceutical product development and why light scattering and optical microscopy methods are typically employed for particle size analysis in drug development and qual…

Posters Released on 07.13.2013
Supply Chain

Effective Controlled Substances Supply Chain Management: What You Need to Know to Ensure Compliance and Optimize Efficiency

Controlled substances are highly regulated and must be vigilantly monitored from the laboratory to the marketplace to prevent theft and illicit sale in the black market, a growing trend. In 2011 there were 36 cases of pharmaceutical cargo theft in th…

White Papers / Tech Papers Released on 07.11.2013
Drug Development

TIMOTHY O’NEILL AND KEVIN KE LLY JOIN DPT LABORATORIES AS BUSINESS DEVELOPMENT MANAGERS

SAN ANTONIO, TX – DPT Laboratories, a contract development and manufacturing organization (CDMO), announced today that it ha s added two new members to its sales team. Timothy J. O’Neill has been named Busine ss Development Manager for D…

News Releases Released on 06.13.2013
Drug Development | Formulation Development | Process Development | Regulatory Affairs | Validation

DPT Laboratories names Kuljit Bhatia Vice President of Research & Development

SAN ANTONIO – DPT Laboratories, a contract development and manufacturing organization (CDMO), announced today that Kuljit S. Bhatia, Ph.D., has been named Vice President of Research & Development.…

News Releases Released on 04.18.2012